Rocket Pharmaceuticals, Inc. (RCKT) Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 11, 20

  • NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”) between February 27, 2025 to May 26, 2025, inclusive (the “Class Period”).